University of Southampton

A first-ever AI-designed vaccine targeting all coronaviruses and animal-borne strains has entered human trials. Initial safety tests with 39 participants succeeded, and larger efficacy studies are planned. The vaccine uses AI to create a 'super-antigen' for broad immunity, potentially reducing the need for frequent flu vaccine updates.

Doctors had near-death experiences that led them to believe in the existence of a soul. These experiences involved unusual sensations and perceptions during clinical death. The doctors' accounts suggest that consciousness may persist beyond physical death.